US7235551B2
(en)
|
2000-03-02 |
2007-06-26 |
Smithkline Beecham Corporation |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
|
KR100850812B1
(ko)
|
2000-10-23 |
2008-08-06 |
스미스클라인 비참 코포레이션 |
신규 화합물
|
EP1425284A2
(en)
|
2001-09-11 |
2004-06-09 |
Smithkline Beecham Corporation |
Furo- and thienopyrimidine derivatives as angiogenesis inhibitors
|
CA2477117A1
(en)
*
|
2002-02-22 |
2003-08-28 |
Teijin Limited |
Pyrrolopyrimidine derivative
|
US7560552B2
(en)
|
2002-03-21 |
2009-07-14 |
Abbott Laboratories |
Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
|
US20030225273A1
(en)
*
|
2002-03-21 |
2003-12-04 |
Michaelides Michael R. |
Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
|
EP1499320B1
(en)
|
2002-04-19 |
2007-08-22 |
Smithkline Beecham Corporation |
Novel compounds
|
CA2494421A1
(en)
|
2002-08-06 |
2004-02-12 |
Astrazeneca Ab |
Condensed pyridines and pyrimidines with tie2 (tek) activity
|
JP2006528685A
(ja)
*
|
2003-05-06 |
2006-12-21 |
スミスクライン ビーチャム コーポレーション |
新規化合物
|
US7297709B2
(en)
|
2003-05-22 |
2007-11-20 |
Abbott Laboratories |
Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
|
US7129260B2
(en)
|
2003-06-02 |
2006-10-31 |
Abbott Laboratories |
Isoindolinone kinase inhibitors
|
US7202363B2
(en)
|
2003-07-24 |
2007-04-10 |
Abbott Laboratories |
Thienopyridine and furopyridine kinase inhibitors
|
US20050026944A1
(en)
*
|
2003-07-24 |
2005-02-03 |
Patrick Betschmann |
Thienopyridine and furopyridine kinase inhibitors
|
MXPA06001098A
(es)
*
|
2003-07-29 |
2006-04-24 |
Irm Llc |
Compuestos y composiciones utiles como inhibidores de proteina cinasa.
|
ATE457313T1
(de)
*
|
2003-12-23 |
2010-02-15 |
Novartis Ag |
Bicyclische heterocyclische p-38-kinase- inhibitoren
|
TW200530236A
(en)
*
|
2004-02-23 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Heteroaryl phenylurea
|
JP2007538068A
(ja)
*
|
2004-05-19 |
2007-12-27 |
アストラゼネカ アクチボラグ |
新規な縮合複素環およびそれらの使用
|
FR2871158A1
(fr)
|
2004-06-04 |
2005-12-09 |
Aventis Pharma Sa |
Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
US20070054916A1
(en)
*
|
2004-10-01 |
2007-03-08 |
Amgen Inc. |
Aryl nitrogen-containing bicyclic compounds and methods of use
|
CA2585934C
(en)
*
|
2004-10-29 |
2013-09-10 |
Abbott Laboratories |
Novel pyrazolopyridine urea kinase inhibitors
|
DE102004061288A1
(de)
*
|
2004-12-14 |
2006-06-29 |
Schering Ag |
3-Amino-Pyrazolo[3,4b]pyridine als Inhibitoren von Proteintyrosinkinasen, deren Herstellung und Verwendung als Arzneimittel
|
PE20061119A1
(es)
|
2005-01-19 |
2006-11-27 |
Aventis Pharma Sa |
PIRAZOLO PIRIDINAS SUSTITUIDAS COMO INHIBIDORES DE CINASAS FAK, KDR Y Tie
|
US7842809B2
(en)
|
2005-01-24 |
2010-11-30 |
Bayer Schering Pharma Ag |
Pyrazolopyridines and salts thereof, a pharmaceutical composition comprising said compounds, a method of preparing same and use of same
|
EP1683796A1
(en)
*
|
2005-01-24 |
2006-07-26 |
Schering Aktiengesellschaft |
Pyrazolopyridines, their preparation and their medical use
|
PE20100737A1
(es)
|
2005-03-25 |
2010-11-27 |
Glaxo Group Ltd |
Nuevos compuestos
|
US7479558B2
(en)
|
2005-03-25 |
2009-01-20 |
Glaxo Group Limited |
Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives
|
PE20061193A1
(es)
|
2005-03-25 |
2006-12-02 |
Glaxo Group Ltd |
DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2-[1H]-0NA COMO INHIBIDORES DE QUINASA p38
|
JP2008535822A
(ja)
|
2005-03-25 |
2008-09-04 |
グラクソ グループ リミテッド |
新規化合物
|
US7884109B2
(en)
|
2005-04-05 |
2011-02-08 |
Wyeth Llc |
Purine and imidazopyridine derivatives for immunosuppression
|
US7795248B2
(en)
*
|
2005-05-18 |
2010-09-14 |
Abbott Laboratories, Inc. |
Substituted 7,8-dihydro-1H-pyrimido[4,5-B][1,4]diazepin-4-amines are novel kinase inhibitors
|
FR2889526B1
(fr)
*
|
2005-08-04 |
2012-02-17 |
Aventis Pharma Sa |
7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
DE102005042742A1
(de)
*
|
2005-09-02 |
2007-03-08 |
Schering Ag |
Substituierte Imidazo[1,2b]pyridazine als Kinase-Inhibitoren, deren Herstellung und Verwendung als Arzneimittel
|
TW200800983A
(en)
*
|
2005-09-14 |
2008-01-01 |
Janssen Pharmaceutica Nv |
5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of C-FMS kinase
|
EP1937681A1
(en)
*
|
2005-09-14 |
2008-07-02 |
Janssen Pharmaceutica N.V. |
5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase
|
PL2385053T3
(pl)
|
2005-11-17 |
2014-05-30 |
Osi Pharmaceuticals Llc |
Związki pośrednie do wytwarzania skondensowanych bicyklicznych inhibitorów mTOR
|
WO2007064931A2
(en)
*
|
2005-12-02 |
2007-06-07 |
Bayer Healthcare Llc |
Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
|
PE20070855A1
(es)
*
|
2005-12-02 |
2007-10-14 |
Bayer Pharmaceuticals Corp |
Derivados de 4-amino-pirrolotriazina sustituida como inhibidores de quinasas
|
EP1981890A2
(en)
*
|
2006-01-25 |
2008-10-22 |
OSI Pharmaceuticals, Inc. |
UNSATURATED mTOR INHIBITORS
|
NZ570530A
(en)
*
|
2006-02-14 |
2011-09-30 |
Vertex Pharma |
Pharmaceutical compositions comprising 6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4)diazepine derivatives
|
US7989459B2
(en)
|
2006-02-17 |
2011-08-02 |
Pharmacopeia, Llc |
Purinones and 1H-imidazopyridinones as PKC-theta inhibitors
|
JP2009527459A
(ja)
*
|
2006-02-23 |
2009-07-30 |
武田薬品工業株式会社 |
縮合窒素含有複素環化合物
|
TW200815437A
(en)
*
|
2006-06-13 |
2008-04-01 |
Bayer Schering Pharma Ag |
Substituted aminopyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
|
WO2008022060A2
(en)
*
|
2006-08-14 |
2008-02-21 |
Novartis Ag |
Imidazo-pyridine derivatives for modulating protein kinase activity
|
US7897762B2
(en)
|
2006-09-14 |
2011-03-01 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of proliferative diseases
|
TW200831104A
(en)
|
2006-10-04 |
2008-08-01 |
Pharmacopeia Inc |
6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
|
AR063141A1
(es)
|
2006-10-04 |
2008-12-30 |
Pharmacopeia Inc |
Derivados de 2- ( benzimidazolil ) purina 8- sustituida para inmunosupresion
|
US7902187B2
(en)
|
2006-10-04 |
2011-03-08 |
Wyeth Llc |
6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
|
BRPI0809088A2
(pt)
*
|
2007-03-22 |
2014-09-09 |
Hoffmann La Roche |
Pirimidodiazepinas substituídas úteis como inibidoras de plk1
|
MX2009012612A
(es)
|
2007-05-23 |
2009-12-07 |
Pharmacopeia Llc |
Purinonas e inhibidores 1h-imidazopiridinonas como pkc-theta.
|
DE102007024470A1
(de)
|
2007-05-24 |
2008-11-27 |
Bayer Schering Pharma Aktiengesellschaft |
Neue Sulfoximin-substituierte Chinolin- bzw. Chinazolinderivate als Kinase-Inhibitoren
|
EP2564850B1
(en)
|
2007-09-25 |
2014-08-13 |
Takeda Pharmaceutical Company Limited |
Polo-like kinase inhibitors
|
EP2072502A1
(de)
|
2007-12-20 |
2009-06-24 |
Bayer Schering Pharma Aktiengesellschaft |
Sulfoximid-substituierte Chinolin- und Chinazolinderivate als Kinase-Inhibitoren
|
CN101239978A
(zh)
*
|
2008-03-05 |
2008-08-13 |
南方医科大学 |
一种咪唑并吡啶类化合物
|
US20100048912A1
(en)
|
2008-03-14 |
2010-02-25 |
Angela Brodie |
Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
|
AU2009225434B2
(en)
|
2008-03-21 |
2014-05-22 |
The University Of Chicago |
Treatment with opioid antagonists and mTOR inhibitors
|
WO2009153197A1
(en)
|
2008-06-18 |
2009-12-23 |
F. Hoffmann-La Roche Ag |
Halo-substituted pyrimidodiazepines as plkl inhibitors
|
MX2011005943A
(es)
|
2008-12-05 |
2011-06-27 |
Abbott Lab |
Derivados de tieno[3,2-c]piridina como inhibidores de cinasa para utilizarse en el tratamiento de cancer.
|
ES2552087T3
(es)
|
2009-02-05 |
2015-11-25 |
Tokai Pharmaceuticals, Inc. |
Nuevos profármacos de inhibidores de CYP17 esteroidales/antiandrógenos
|
EP2789615B1
(en)
*
|
2009-08-11 |
2017-05-03 |
Bristol-Myers Squibb Company |
Azaindazoles as Btk kinase modulators and use thereof
|
KR20120094920A
(ko)
|
2009-09-25 |
2012-08-27 |
버텍스 파마슈티칼스 인코포레이티드 |
단백질 키나제 억제제로서 유용한 피리미딘 유도체의 제조 방법
|
WO2011038185A2
(en)
|
2009-09-25 |
2011-03-31 |
Vertex Pharmaceuticals Incorporated |
Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors
|
MX2012009208A
(es)
*
|
2010-02-08 |
2012-09-07 |
Msd Oss Bv |
Compuestos de 8-metil-1-fenil-imidazol[1, 5-a]pirazina.
|
HUE030720T2
(en)
|
2010-05-31 |
2017-06-28 |
Ono Pharmaceutical Co |
Purinone derivative as btk kinase inhibitor
|
AU2015202128B2
(en)
*
|
2010-05-31 |
2015-05-28 |
Ono Pharmaceutical Co., Ltd. |
Purinone derivative
|
EP3495368B1
(en)
|
2011-07-19 |
2023-05-31 |
Merck Sharp & Dohme B.V. |
(s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-2-methoxy-n-(pyridin-2-yl)benzamide as btk-inhibitor
|
EP2548877A1
(en)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
WO2013012909A1
(en)
|
2011-07-20 |
2013-01-24 |
Abbott Laboratories |
Kinase inhibitor with improved aqueous solubility
|
LT2786996T
(lt)
|
2011-11-29 |
2017-01-10 |
Ono Pharmaceutical Co., Ltd. |
Purinono darinio hidrochloridas
|
UY34484A
(es)
|
2011-12-15 |
2013-07-31 |
Bayer Ip Gmbh |
Benzotienilo-pirrolotriazinas disustituidas y sus usos
|
US9598416B2
(en)
|
2011-12-15 |
2017-03-21 |
Bayer Intellectual Property Gmbh |
Substituted benzothienyl-pyrrolotriazines and uses thereof in the treatment cancer
|
US8501724B1
(en)
*
|
2012-01-31 |
2013-08-06 |
Pharmacyclics, Inc. |
Purinone compounds as kinase inhibitors
|
WO2013124316A1
(en)
|
2012-02-23 |
2013-08-29 |
Bayer Intellectual Property Gmbh |
Substituted benzothienyl-pyrrolotriazines and uses thereof
|
RU2678767C2
(ru)
|
2012-05-31 |
2019-02-01 |
ГБ005, Инк. |
Ингибиторы протеинкиназ
|
CA2782774A1
(en)
*
|
2012-07-06 |
2014-01-06 |
Pharmascience Inc. |
Protein kinase inhibitors
|
CN105796569A
(zh)
*
|
2012-09-10 |
2016-07-27 |
杨子娇 |
化合物在制备防治青光眼病的药物中的用途
|
CN105796562A
(zh)
*
|
2012-09-10 |
2016-07-27 |
杨子娇 |
化合物在制备防治青光眼病的药物中的用途
|
US20140206681A1
(en)
|
2013-01-23 |
2014-07-24 |
Ronald M. Kim |
Btk inhibitors
|
WO2014113942A1
(en)
|
2013-01-23 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
EP4066841A1
(en)
|
2013-03-14 |
2022-10-05 |
University of Maryland, Baltimore |
Androgen receptor down-regulating agents and uses thereof
|
JP6458018B2
(ja)
*
|
2013-07-02 |
2019-01-23 |
ファーマサイクリックス エルエルシー |
キナーゼ阻害剤としてのプリノン化合物
|
EP3033088A4
(en)
|
2013-08-12 |
2017-03-08 |
Tokai Pharmaceuticals, Inc. |
Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies
|
CA2833701A1
(en)
*
|
2013-11-19 |
2015-05-19 |
Pharmascience Inc. |
Protein kinase inhibitors
|
CA2833867A1
(en)
*
|
2013-11-21 |
2015-05-21 |
Pharmascience Inc. |
Protein kinase inhibitors
|
US10328080B2
(en)
|
2013-12-05 |
2019-06-25 |
Acerta Pharma, B.V. |
Therapeutic combination of PI3K inhibitor and a BTK inhibitor
|
US9637486B2
(en)
|
2013-12-20 |
2017-05-02 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
US9834554B2
(en)
|
2013-12-20 |
2017-12-05 |
Merck Sharp & Dohme Corp. |
BTK inhibitors
|
US10428331B2
(en)
|
2014-01-16 |
2019-10-01 |
Musc Foundation For Research Development |
Targeted nanocarriers for the administration of immunosuppressive agents
|
US10272083B2
(en)
|
2014-01-21 |
2019-04-30 |
Acerta Pharma B.V. |
Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor
|
US9416131B2
(en)
|
2014-03-25 |
2016-08-16 |
Ono Pharmaceutical Co., Ltd. |
Prophylactic agent and/or therapeutic agent for diffuse large B-cell lymphoma
|
US9937171B2
(en)
|
2014-04-11 |
2018-04-10 |
Acerta Pharma B.V. |
Methods of blocking the CXCR-4/SDF-1 signaling pathway with inhibitors of bruton's tyrosine kinase
|
WO2015193740A2
(en)
|
2014-06-17 |
2015-12-23 |
Acerta Pharma B.V. |
Therapeutic combinations of a btk inhibitor, a pi3k inhibitor and/or a jak-2 inhibitor
|
RS62713B1
(sr)
|
2014-08-11 |
2022-01-31 |
Acerta Pharma Bv |
Terapeutske kombinacije btk inhibitora i bcl-2 inhibitora
|
WO2016106623A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Benzamide imidazopyrazine btk inhibitors
|
WO2016106624A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Tertiary alcohol imidazopyrazine btk inhibitors
|
WO2016106629A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2016106628A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
WO2016106626A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Imidazopyrazine analogs with 3-tertiary carbon substitutions as btk inhibitors
|
EP3281943B1
(en)
|
2015-04-09 |
2023-06-28 |
ONO Pharmaceutical Co., Ltd. |
Process for producing purinone derivative
|
JP6829215B2
(ja)
|
2015-07-02 |
2021-02-10 |
アセルタ ファーマ ビー.ブイ. |
(S)−4−(8−アミノ−3−(1−(ブト−2−イノイル)ピロリジン−2−イル)イミダゾ[1,5−a]ピラジン−1−イル)−N−(ピリジン−2−イル)ベンザミドの固体形態及び製剤
|
CN105130932B
(zh)
*
|
2015-07-14 |
2017-06-16 |
中国科学院微生物研究所 |
化合物及其在制备ptp1b抑制剂和治疗和/或预防ⅱ型糖尿病的药物的用途
|
WO2017035366A1
(en)
|
2015-08-26 |
2017-03-02 |
Incyte Corporation |
Pyrrolopyrimidine derivatives as tam inhibitors
|
RS65129B1
(sr)
*
|
2016-03-28 |
2024-02-29 |
Incyte Corp |
Jedinjenja pirolotriazina kao inhibitori tam
|
US10280164B2
(en)
|
2016-09-09 |
2019-05-07 |
Incyte Corporation |
Pyrazolopyridone compounds and uses thereof
|
WO2018049214A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
|
WO2018049152A1
(en)
|
2016-09-09 |
2018-03-15 |
Incyte Corporation |
Pyrazolopyrimidine derivatives as hpk1 modulators and uses thereof for the treatment of cancer
|
MX2019002750A
(es)
|
2016-09-09 |
2019-07-04 |
Incyte Corp |
Derivados de pirazolopiridina como moduladores de cinasa 1 progenitora hematopoyetica (hpk1) y usos de los mismos para tratamiento de cancer.
|
US20180228786A1
(en)
|
2017-02-15 |
2018-08-16 |
Incyte Corporation |
Pyrazolopyridine compounds and uses thereof
|
US10722495B2
(en)
|
2017-09-08 |
2020-07-28 |
Incyte Corporation |
Cyanoindazole compounds and uses thereof
|
WO2019067594A1
(en)
|
2017-09-27 |
2019-04-04 |
Incyte Corporation |
SALTS OF PYRROLOTRIAZINE DERIVATIVES USEFUL AS TAM INHIBITORS
|
AU2019223955A1
(en)
|
2018-02-20 |
2020-10-08 |
Incyte Corporation |
N-(phenyl)-2-(phenyl)pyrimidine-4-carboxamide derivatives and related compounds as HPK1 inhibitors for treating cancer
|
US10745388B2
(en)
|
2018-02-20 |
2020-08-18 |
Incyte Corporation |
Indazole compounds and uses thereof
|
US10752635B2
(en)
|
2018-02-20 |
2020-08-25 |
Incyte Corporation |
Indazole compounds and uses thereof
|
US11299473B2
(en)
|
2018-04-13 |
2022-04-12 |
Incyte Corporation |
Benzimidazole and indole compounds and uses thereof
|
PE20211805A1
(es)
|
2018-06-29 |
2021-09-14 |
Incyte Corp |
Formulaciones de un inhibidor de axl/mer
|
US10899755B2
(en)
|
2018-08-08 |
2021-01-26 |
Incyte Corporation |
Benzothiazole compounds and uses thereof
|
MA53726A
(fr)
|
2018-09-25 |
2022-05-11 |
Incyte Corp |
Composés pyrazolo[4,3-d]pyrimidine en tant que modulateurs des alk2 et/ou fgfr
|
JP2022543155A
(ja)
|
2019-08-06 |
2022-10-07 |
インサイト・コーポレイション |
Hpk1阻害剤の固体形態
|